UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular Pathways: Estrogen Pathway in Colorectal Cancer

Clinical cancer research, 2013-11, Vol.19 (21), p.5842-5848

2013

Volltextzugriff (PDF)

Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence

Clinical cancer research, 2012-02, Vol.18 (3), p.645-653

2012

Volltextzugriff (PDF)

Influence of Sex on the Survival of Patients With Esophageal Cancer

Journal of clinical oncology, 2012-06, Vol.30 (18), p.2265-2272

2012

Volltextzugriff (PDF)

Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance

Cancers, 2024-08, Vol.16 (16), p.2797

2024

Volltextzugriff (PDF)

Inflammation and Prostate Cancer: A Multidisciplinary Approach to Identifying Opportunities for Treatment and Prevention

Cancers, 2022-03, Vol.14 (6), p.1367

2022

Volltextzugriff (PDF)

The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models

Molecular cancer therapeutics, 2012-06, Vol.11 (6), p.1353-1364

2012

Volltextzugriff (PDF)

A novel fluorescence-based assay for the rapid detection and quantification of cellular deoxyribonucleoside triphosphates

Nucleic acids research, 2011-09, Vol.39 (17), p.e112-e112

2011

Volltextzugriff (PDF)

DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines

BMC medical genomics, 2009-11, Vol.2 (1), p.67-67, Article 67

2009

Volltextzugriff (PDF)

Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage

Nucleic acids research, 2009-01, Vol.37 (1), p.78-95

2009

Volltextzugriff (PDF)

Novel opportunities for thymidylate metabolism as a therapeutic target

Molecular cancer therapeutics, 2008-09, Vol.7 (9), p.3029-3037

2008

Volltextzugriff (PDF)

Pancreatic Cancer: Medical Management (Novel Chemotherapeutics)

Gastroenterology clinics of North America, 2012-03, Vol.41 (1), p.189-209

2012

Volltextzugriff (PDF)

Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer

NPJ breast cancer, 2021-04, Vol.7 (1), p.38-38, Article 38

2021

Volltextzugriff (PDF)

Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models

International journal of cancer, 2011-05, Vol.128 (9), p.2038-2049

2011

Volltextzugriff (PDF)

Sustained inhibition of deacetylases is required for the antitumor activity of the histone deactylase inhibitors panobinostat and vorinostat in models of colorectal cancer

Investigational new drugs, 2013-08, Vol.31 (4), p.845-857

2013

Volltextzugriff (PDF)

Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States

Molecular cancer therapeutics, 2013-10, Vol.12 (10), p.2261-2272

2013

Volltextzugriff (PDF)

Prostate cancer heterogeneity assessment with multi-regional sampling and alignment-free methods

NAR genomics and bioinformatics, 2020-09, Vol.2 (3)

2020

Volltextzugriff (PDF)

Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer

Molecular cancer therapeutics, 2023-01, Vol.22 (1), p.135-149

2023

Volltextzugriff (PDF)

The Dual EGFR/HER2 Inhibitor Lapatinib Synergistically Enhances the Antitumor Activity of the Histone Deacetylase Inhibitor Panobinostat in Colorectal Cancer Models

Cancer research (Chicago, Ill.), 2011-05, Vol.71 (10), p.3635-3648

2011

Volltextzugriff (PDF)

Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate Cancers

Molecular cancer research, 2022-06, Vol.20 (6), p.841-853

2022

Volltextzugriff (PDF)

Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence

Clinical cancer research, 2011-11, Vol.17 (21), p.6934-6943

2011

Volltextzugriff (PDF)

Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer

Clinical cancer research, 2011-09, Vol.17 (17), p.5783-5792

2011

Volltextzugriff (PDF)

The Unfolded Protein Response: A Novel Therapeutic Target for Poor Prognostic BRAF Mutant Colorectal Cancer

Molecular cancer therapeutics, 2018-06, Vol.17 (6), p.1280-1290

2018

Volltextzugriff (PDF)

Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy

Molecular cancer therapeutics, 2014-02, Vol.13 (2), p.528-539

2014

Volltextzugriff (PDF)

Inhibition of dUTPase induces synthetic lethality with thymidylate synthase-targeted therapies in non-small cell lung cancer

Molecular cancer therapeutics, 2012-03, Vol.11 (3), p.616-628

2012

Volltextzugriff (PDF)

A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression

Molecular cancer research, 2011-05, Vol.9 (5), p.660-670

2011

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(42)
Humans
(39)
Oncology
(33)
Male
(17)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Tumors
(14)
Cell Line, Tumor
(13)
Female
(13)
Aged
(12)
Gastroenterology. Liver. Pancreas. Abdomen
(12)
Middle Aged
(12)
Animals
(10)
Antineoplastic Agents - Pharmacology
(10)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(10)
Colorectal Neoplasms - Drug Therapy
(9)
Colorectal Neoplasms - Genetics
(9)
Antineoplastic Agents
(8)
Pharmacology. Drug Treatments
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Molecular Pathways: Estrogen Pathway in Colorectal Cancer

Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence

Influence of Sex on the Survival of Patients With Esophageal Cancer

Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance

Inflammation and Prostate Cancer: A Multidisciplinary Approach to Identifying Opportunities for Treatment and Prevention

The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models

A novel fluorescence-based assay for the rapid detection and quantification of cellular deoxyribonucleoside triphosphates

DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines

Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage

Novel opportunities for thymidylate metabolism as a therapeutic target

Pancreatic Cancer: Medical Management (Novel Chemotherapeutics)

Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer

Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models

Sustained inhibition of deacetylases is required for the antitumor activity of the histone deactylase inhibitors panobinostat and vorinostat in models of colorectal cancer

Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States

Prostate cancer heterogeneity assessment with multi-regional sampling and alignment-free methods

Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer

The Dual EGFR/HER2 Inhibitor Lapatinib Synergistically Enhances the Antitumor Activity of the Histone Deacetylase Inhibitor Panobinostat in Colorectal Cancer Models

Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate Cancers

Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence

Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer

The Unfolded Protein Response: A Novel Therapeutic Target for Poor Prognostic BRAF Mutant Colorectal Cancer

Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy

Inhibition of dUTPase induces synthetic lethality with thymidylate synthase-targeted therapies in non-small cell lung cancer

A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression

Suchergebnisse filtern